CARIS LIFE SCIENCES, INC. for CARIS LIFE SCIENCES, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Role of molecular profiling in cancer care; access to molecular profiling technologies in Medicare; prior authorization reform in Medicare; Date of Service Rule Reform for lab services; Medicare payment for Software as a Medical Service (SaMS); and appropriate reimbursement for cutting edge cancer diagnostic testing, including PAMA reporting.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TARA BURKE New | — |
Health Issues HCR
Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; S 2355, Patients Deserve Price Tags; Medicare payment for Software as a Medical Service (SaMS)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TARA BURKE New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.